Inspirion Wealth Advisors, LLC Abb Vie Inc. Transaction History

Inspirion Wealth Advisors, LLC

$711 Million
Q3 2024

A detailed history of Inspirion Wealth Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Inspirion Wealth Advisors, LLC holds 202,312 shares of ABBV stock, worth $35.5 Million. This represents 5.62% of its overall portfolio holdings.

Number of Shares

202,312

Previous 207,008 2.27%

Holding current value

$35.5 Million

Previous $35.5 Million 12.52%

% of portfolio

5.62%

Previous 5.46%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	SELL	$163.84 - $199.33 $769,392 - $936,053	-4,696 Reduced 2.27%	202,312 $40 Million
Q2 2024 Jul 12, 2024	SELL	$154.79 - $180.76 $272,120 - $317,776	-1,758 Reduced 0.84%	207,008 $35.5 Million
Q1 2024 Apr 12, 2024	SELL	$159.82 - $182.1 $282,721 - $322,134	-1,769 Reduced 0.84%	208,766 $38 Million
Q4 2023 Jan 10, 2024	SELL	$137.6 - $154.97 $130,857 - $147,376	-951 Reduced 0.45%	210,535 $32.6 Million
Q3 2023 Oct 13, 2023	SELL	$133.59 - $154.65 $3.62 Million - $4.19 Million	-27,078 Reduced 11.35%	211,486 $31.5 Million
Q2 2023 Jul 20, 2023	SELL	$132.51 - $164.9 $177,960 - $221,460	-1,343 Reduced 0.56%	238,564 $32.1 Million
Q1 2023 Apr 07, 2023	SELL	$144.61 - $166.54 $816,612 - $940,451	-5,647 Reduced 2.3%	239,907 $38.2 Million
Q4 2022 Jan 18, 2023	SELL	$138.31 - $165.87 $664,441 - $796,839	-4,804 Reduced 1.92%	245,554 $0
Q3 2022 Oct 18, 2022	BUY	$134.21 - $153.93 $112,870 - $129,455	841 Added 0.34%	250,358 $33.6 Million
Q2 2022 Jul 27, 2022	SELL	$137.62 - $174.96 $18,028 - $22,919	-131 Reduced 0.05%	249,517 $38.2 Million
Q1 2022 Apr 14, 2022	BUY	$131.98 - $163.75 $1.97 Million - $2.44 Million	14,917 Added 6.35%	249,648 $40.5 Million
Q4 2021 Jan 21, 2022	BUY	$107.43 - $135.93 $462,378 - $585,042	4,304 Added 1.87%	234,731 $31.8 Million
Q3 2021 Oct 08, 2021	SELL	$106.4 - $120.78 $62,031 - $70,414	-583 Reduced 0.25%	230,427 $24.9 Million
Q2 2021 Jul 16, 2021	SELL	$105.21 - $117.21 $384,858 - $428,754	-3,658 Reduced 1.56%	231,010 $26 Million
Q1 2021 Apr 15, 2021	BUY	$102.3 - $112.62 $4.45 Million - $4.9 Million	43,529 Added 22.77%	234,668 $25.4 Million
Q4 2020 Jan 22, 2021	BUY	$80.49 - $108.67 $217,403 - $293,517	2,701 Added 1.43%	191,139 $20.5 Million
Q3 2020 Oct 14, 2020	BUY	$85.91 - $100.83 $648,362 - $760,964	7,547 Added 4.17%	188,438 $16.5 Million
Q2 2020 Jul 09, 2020	BUY	$73.37 - $98.18 $352,542 - $471,754	4,805 Added 2.73%	180,891 $17.8 Million
Q1 2020 Apr 23, 2020	BUY	$64.5 - $97.79 $193,048 - $292,685	2,993 Added 1.73%	176,086 $13.4 Million
Q4 2019 Jan 14, 2020	BUY	$72.13 - $90.25 $315,208 - $394,392	4,370 Added 2.59%	173,093 $15.3 Million
Q3 2019 Oct 22, 2019	SELL	$62.98 - $75.72 $1.4 Million - $1.68 Million	-22,219 Reduced 11.64%	168,723 $12.8 Million
Q2 2019 Jul 15, 2019	SELL	$65.7 - $83.98 $96,316 - $123,114	-1,466 Reduced 0.76%	190,942 $13.9 Million
Q1 2019 Apr 16, 2019	SELL	$77.14 - $90.79 $550,471 - $647,877	-7,136 Reduced 3.58%	192,408 $15.5 Million
Q4 2018 Jan 22, 2019	SELL	$77.85 - $96.01 $195,014 - $240,505	-2,505 Reduced 1.24%	199,544 $18.4 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $189,733 - $210,924	2,134 Added 1.07%	202,049 $19.1 Million
Q2 2018 Jul 19, 2018	BUY	$89.78 - $106.23 $132,066 - $156,264	1,471 Added 0.74%	199,915 $18.5 Million
Q1 2018 Apr 18, 2018	BUY	$92.01 - $123.21 $72,043 - $96,473	783 Added 0.4%	198,444 $18.8 Million
Q4 2017 Jan 16, 2018	SELL	$89.56 - $98.21 $365,494 - $400,795	-4,081 Reduced 2.02%	197,661 $19.1 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $14.1 Million - $18 Million	201,742	201,742 $17.9 Million

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspirion Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspirion Wealth Advisors, LLC with notifications on news.

Account

Inspirion Wealth Advisors, LLC Abb Vie Inc. Transaction History